Retrospective review of accelerated daratumumab administration

Patel, A; Clark, S; Espiritu, J; Dechen, T; Tran, Q

Patel, A (通讯作者),Beth Israel Deaconess Med Ctr, One Deaconess Rd,Rosenberg Bldg, Boston, MA 02215 USA.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022; 28 (4): 816

Abstract

Daratumumab is an anti-CD38 monoclonal antibody approved for multiple myeloma. The initial infusion is administered over a median of 7.5 hours with su......

Full Text Link